•  
  •  
  •  
  •  

2026-08-14 09:28:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  Treatment

Stock Report

  • OIL Green Energy Ltd and Hindustan Waste Treatment Pvt. Ltd. Sign Joint Venture agreement for Bioenergy and Sustainable Resource Recovery Initiatives
  • Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
  • L&T wins significant orders for Water & Effluent Treatment Business
  • SPARC announces submission of IND Application for SBO-154 to USFDA
  • Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment
  • Wockhardt's Investigational Drug, Zaynich™ cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use
  • Sun Pharma introduces a novel treatment, STARIZO in India for acute bacterial skin and skin structure infections
  • Zydus receives approval from COFEPRIS of Mexico to market Mamitra™ to treat various cancers
  • Zydus receives approval from COFEPRIS of Mexico to market Bhavaâ„¢ to treat various cancers
  • Taylormade Renewables Ltd uses patented TRL RAIN technology used for Treating SABIC Petroleum Refinery Effluent
  • Dr. Reddy's Laboratories SA enters into agreement for COYA 302
  • L&T Construction bags contracts for its Water & Effluent Treatment Business
  • Lupin Launches Tiotropium Dry Powder for Inhaler for the Treatment of COPD in the United States
  • Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment in Germany
  • Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment
  • Sun Pharma launches CEQUA®, a novel therapy for Dry Eye Disease in India
  • L&T Construction bags Water Transport System and Construction Order
  • Taylormade Renewables Ltd wins award
  • Themis Medicare Launches Lenzetto®
  • L&T Construction wins order for its Water & Effluent Treatment Business
  • L&T Construction bags various contracts for its Water & Effluent Treatment Business
  • Shilpa Medicare Ltd launches Capecitabine 1000 MG dispersible tablet
  • Apollo Hospital, Jubilee Hills, Hyderabad launches Vertigo and Balance Disorder Clinic in Hyderabad
  • L&T Construction secures significant orders for its Water & Effluent Treatment Business

Industry News

  • Verizon India in association with Adyar Cancer Institute inaugurates Linear Accelerator radiotherapy equipment for cancer patients

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025